Impact of Monacolin K‐Containing Supplements on Lipid Profile: A Meta‐Analysis of Randomised Controlled Trials
These results highlight the potential of monacolin K as a promising adjunct therapy for hypercholesterolemia management, especially for patients who have not achieved LDL-C targets with standard care or are intolerant to or unwilling to use statin therapy.
Authors
- Prashant Kesharwani (ORCID: https://orcid.org/0000-0002-0890-769X)
- Elaheh Mirhadi
- Sercan Karav
Institutions
- Çanakkale Onsekiz Mart Üniversitesi (TR)
- Mashhad University of Medical Sciences (IR)
- Biotechnology Research Center (IR)
- Chitkara University (IN)
- Dr. Hari Singh Gour University (IN)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1002/edm2.70166
- Primary Topic
- Microbial Metabolism and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00